Xeris Pharmaceuticals, Inc.
- Targets
- 1
- Filings
- 1
- Median premium
- 78%
- First filing
- Jul 29, 2021
- Latest filing
- Jul 29, 2021
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| Strongbridge Biopharma plc | — | — | 1 | Jul 29, 2021 |
Deal filings
| Filed | Company | Form | Price | Premium |
|---|---|---|---|---|
| Jul 29, 2021 | Strongbridge Biopharma plc | DEFM14A | $0.78 | 78.4% |